Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLISSAFE Study
2014-004517-84Phase 2Completed
- Sponsor
- ITF Pharma
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vaginal atrophy comparing Estriol vaginal gel with Placebo vaginal gel (2 arms). Primary endpoint: Variation in serum levels of FSH from baseline to 12 weeks of treatment. Started Jan 2015; status: completed.
02
Drugs
estriol
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on 2014-004517-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004517-84.